Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Keratin-17 | 8 | 2024 | 8 | 1.280 |
Why?
|
Lung Neoplasms | 8 | 2024 | 654 | 1.160 |
Why?
|
Biomarkers, Tumor | 10 | 2024 | 502 | 0.910 |
Why?
|
Spectrophotometry, Infrared | 4 | 2016 | 26 | 0.730 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 44 | 0.600 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 177 | 0.540 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2024 | 111 | 0.520 |
Why?
|
Immunohistochemistry | 9 | 2024 | 887 | 0.470 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 35 | 0.470 |
Why?
|
Histological Techniques | 1 | 2015 | 18 | 0.470 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 339 | 0.450 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 283 | 0.440 |
Why?
|
Pulmonary Aspergillosis | 2 | 2023 | 10 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 162 | 0.340 |
Why?
|
Adenocarcinoma | 3 | 2019 | 334 | 0.320 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2017 | 140 | 0.320 |
Why?
|
Prognosis | 7 | 2024 | 1716 | 0.270 |
Why?
|
Endometrial Neoplasms | 2 | 2019 | 55 | 0.250 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 144 | 0.240 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2017 | 29 | 0.230 |
Why?
|
Lipoma | 1 | 2025 | 18 | 0.230 |
Why?
|
Ankle | 1 | 2025 | 27 | 0.230 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2024 | 8 | 0.230 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 18 | 0.230 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2023 | 5 | 0.210 |
Why?
|
Cryptococcus neoformans | 2 | 2017 | 148 | 0.210 |
Why?
|
Humans | 31 | 2025 | 62462 | 0.210 |
Why?
|
Esophageal Diseases | 1 | 2023 | 16 | 0.210 |
Why?
|
Aspergillosis | 1 | 2023 | 40 | 0.210 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 266 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 512 | 0.200 |
Why?
|
Adenoma | 2 | 2013 | 68 | 0.200 |
Why?
|
Drug Carriers | 2 | 2017 | 179 | 0.190 |
Why?
|
Carcinoma, Endometrioid | 2 | 2019 | 19 | 0.190 |
Why?
|
Microscopy | 1 | 2022 | 91 | 0.180 |
Why?
|
Polyesters | 1 | 2021 | 48 | 0.180 |
Why?
|
Influenza, Human | 1 | 2023 | 206 | 0.180 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2020 | 8 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2020 | 11 | 0.170 |
Why?
|
Aspirin | 1 | 2021 | 171 | 0.160 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 83 | 0.160 |
Why?
|
Cystadenofibroma | 1 | 2019 | 1 | 0.160 |
Why?
|
V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2019 | 2 | 0.160 |
Why?
|
Inflammation | 3 | 2023 | 1136 | 0.160 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 39 | 0.160 |
Why?
|
Skin Neoplasms | 1 | 2024 | 413 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 255 | 0.160 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 55 | 0.160 |
Why?
|
Pancreas | 1 | 2019 | 148 | 0.150 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 79 | 0.150 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 61 | 0.150 |
Why?
|
Lymph Nodes | 1 | 2019 | 222 | 0.140 |
Why?
|
Observer Variation | 1 | 2018 | 211 | 0.140 |
Why?
|
Squamous Intraepithelial Lesions of the Cervix | 1 | 2017 | 1 | 0.140 |
Why?
|
Cryptococcus gattii | 1 | 2017 | 12 | 0.140 |
Why?
|
Biopsy, Fine-Needle | 3 | 2023 | 62 | 0.140 |
Why?
|
Female | 17 | 2025 | 32378 | 0.140 |
Why?
|
Antigens, Fungal | 1 | 2017 | 57 | 0.140 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 139 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2017 | 56 | 0.140 |
Why?
|
Fungal Vaccines | 1 | 2017 | 46 | 0.140 |
Why?
|
Interleukin-23 | 1 | 2017 | 18 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2017 | 147 | 0.130 |
Why?
|
Eosinophils | 1 | 2017 | 46 | 0.130 |
Why?
|
Cryptococcosis | 1 | 2017 | 79 | 0.130 |
Why?
|
Hypersensitivity | 1 | 2017 | 61 | 0.130 |
Why?
|
Spectrum Analysis, Raman | 1 | 2016 | 23 | 0.130 |
Why?
|
Interleukin-17 | 1 | 2017 | 94 | 0.130 |
Why?
|
Eosinophilic Granuloma | 1 | 2015 | 3 | 0.130 |
Why?
|
Knee | 1 | 2015 | 37 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 31 | 0.120 |
Why?
|
Middle Aged | 10 | 2024 | 17294 | 0.120 |
Why?
|
Male | 11 | 2025 | 29368 | 0.120 |
Why?
|
Morpholinos | 2 | 2012 | 52 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2025 | 959 | 0.110 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 192 | 0.110 |
Why?
|
Smoking | 1 | 2019 | 864 | 0.110 |
Why?
|
Smoking Cessation | 1 | 2019 | 551 | 0.110 |
Why?
|
RNA, Messenger | 1 | 2019 | 1520 | 0.110 |
Why?
|
Aged | 8 | 2024 | 14203 | 0.100 |
Why?
|
Lactation Disorders | 1 | 2013 | 4 | 0.100 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2013 | 11 | 0.100 |
Why?
|
Lung | 4 | 2023 | 937 | 0.100 |
Why?
|
Indium Radioisotopes | 2 | 2012 | 41 | 0.100 |
Why?
|
Streptavidin | 2 | 2012 | 32 | 0.100 |
Why?
|
Survival Rate | 3 | 2021 | 837 | 0.100 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 186 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2024 | 5390 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2015 | 928 | 0.100 |
Why?
|
Asthma | 1 | 2017 | 433 | 0.100 |
Why?
|
Picolinic Acids | 1 | 2012 | 7 | 0.100 |
Why?
|
Streptococcus pyogenes | 1 | 2012 | 30 | 0.100 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 37 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 52 | 0.100 |
Why?
|
Receptors, Interleukin-18 | 1 | 2011 | 10 | 0.090 |
Why?
|
Catenins | 1 | 2011 | 13 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2012 | 79 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2012 | 65 | 0.090 |
Why?
|
Receptors, Interleukin-1 | 1 | 2011 | 66 | 0.090 |
Why?
|
Cadherins | 1 | 2011 | 77 | 0.090 |
Why?
|
Antibodies | 1 | 2012 | 182 | 0.090 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2011 | 60 | 0.090 |
Why?
|
Mice | 8 | 2023 | 10768 | 0.090 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2011 | 204 | 0.090 |
Why?
|
Radioisotopes | 1 | 2010 | 24 | 0.090 |
Why?
|
Insulin-Secreting Cells | 1 | 2012 | 190 | 0.090 |
Why?
|
Aspergillus fumigatus | 2 | 2023 | 51 | 0.080 |
Why?
|
Toll-Like Receptor 9 | 1 | 2011 | 211 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2019 | 485 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 188 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2021 | 240 | 0.080 |
Why?
|
DNA, Antisense | 1 | 2009 | 17 | 0.080 |
Why?
|
Animals | 9 | 2023 | 20531 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 394 | 0.080 |
Why?
|
Skin | 1 | 2012 | 377 | 0.080 |
Why?
|
Adult | 6 | 2024 | 16567 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 218 | 0.080 |
Why?
|
Cytodiagnosis | 2 | 2022 | 46 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 1076 | 0.070 |
Why?
|
Proteins | 1 | 2012 | 747 | 0.070 |
Why?
|
Nanoparticles | 2 | 2012 | 517 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2011 | 770 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 416 | 0.060 |
Why?
|
Fluorouracil | 1 | 2024 | 66 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2024 | 42 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 1582 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2015 | 1443 | 0.050 |
Why?
|
Glass | 1 | 2023 | 22 | 0.050 |
Why?
|
Mental Recall | 1 | 2023 | 90 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2023 | 80 | 0.050 |
Why?
|
Necrosis | 1 | 2023 | 143 | 0.050 |
Why?
|
Esophagectomy | 1 | 2023 | 48 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 2439 | 0.050 |
Why?
|
Isotope Labeling | 2 | 2012 | 70 | 0.050 |
Why?
|
Cytological Techniques | 1 | 2022 | 26 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2025 | 2141 | 0.050 |
Why?
|
Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2021 | 2 | 0.050 |
Why?
|
Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 12 | 0.050 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 31 | 0.050 |
Why?
|
Mechanical Phenomena | 1 | 2021 | 21 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2021 | 137 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 5554 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 1003 | 0.040 |
Why?
|
Young Adult | 3 | 2017 | 4610 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2017 | 2165 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2019 | 87 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 620 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 208 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2019 | 89 | 0.040 |
Why?
|
Mediastinum | 1 | 2019 | 28 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 187 | 0.040 |
Why?
|
Neoplasms | 1 | 2009 | 1344 | 0.040 |
Why?
|
Dyspnea | 1 | 2019 | 121 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 159 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2021 | 6486 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2017 | 40 | 0.040 |
Why?
|
Lung Diseases, Fungal | 1 | 2017 | 34 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2017 | 71 | 0.040 |
Why?
|
Biopsy | 1 | 2019 | 429 | 0.030 |
Why?
|
Glucans | 1 | 2017 | 65 | 0.030 |
Why?
|
Rats | 1 | 2021 | 1976 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2017 | 384 | 0.030 |
Why?
|
Cell Separation | 1 | 2017 | 147 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2021 | 2148 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2016 | 11 | 0.030 |
Why?
|
Vibration | 1 | 2016 | 26 | 0.030 |
Why?
|
Survival Analysis | 1 | 2017 | 575 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 234 | 0.030 |
Why?
|
Cell Biology | 1 | 2016 | 22 | 0.030 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2015 | 16 | 0.030 |
Why?
|
Image-Guided Biopsy | 1 | 2015 | 40 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2017 | 698 | 0.030 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 45 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 641 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2017 | 669 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 113 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 892 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 671 | 0.030 |
Why?
|
Gene Expression | 1 | 2017 | 834 | 0.030 |
Why?
|
Proteolysis | 1 | 2015 | 144 | 0.030 |
Why?
|
Ultrasonography | 1 | 2015 | 470 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 2530 | 0.030 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2012 | 9 | 0.030 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2012 | 4 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2012 | 13 | 0.030 |
Why?
|
Escherichia coli | 1 | 2017 | 708 | 0.030 |
Why?
|
Thoracotomy | 1 | 2013 | 46 | 0.030 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2012 | 31 | 0.020 |
Why?
|
Endometriosis | 1 | 2012 | 29 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2015 | 163 | 0.020 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2012 | 8 | 0.020 |
Why?
|
Multiplex Polymerase Chain Reaction | 1 | 2012 | 15 | 0.020 |
Why?
|
Biotinylation | 1 | 2012 | 36 | 0.020 |
Why?
|
Chelating Agents | 1 | 2012 | 50 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2016 | 1636 | 0.020 |
Why?
|
Multimodal Imaging | 1 | 2012 | 66 | 0.020 |
Why?
|
Rhenium | 1 | 2010 | 8 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 208 | 0.020 |
Why?
|
Antibodies, Neoplasm | 1 | 2010 | 26 | 0.020 |
Why?
|
Protein Binding | 1 | 2015 | 1595 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2010 | 86 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 146 | 0.020 |
Why?
|
Morpholines | 1 | 2010 | 89 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2012 | 198 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 128 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 292 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 3384 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 5288 | 0.020 |
Why?
|
Spleen | 1 | 2010 | 482 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 1138 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 643 | 0.020 |
Why?
|
Mice, Nude | 1 | 2009 | 270 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 313 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 207 | 0.020 |
Why?
|
Pilot Projects | 1 | 2012 | 983 | 0.020 |
Why?
|
Kidney | 1 | 2010 | 444 | 0.020 |
Why?
|
Cell Line | 1 | 2012 | 2033 | 0.020 |
Why?
|
Cell Survival | 1 | 2009 | 572 | 0.020 |
Why?
|
United States | 1 | 2019 | 7696 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2011 | 2093 | 0.020 |
Why?
|
Liver | 1 | 2010 | 838 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 2308 | 0.020 |
Why?
|